AMSTERDAM – The European Medicines Agency is meeting Monday to consider approving a coronavirus vaccine developed by BioNTech and Pfizer that would be the first to be authorized for use in the European Union.The closed-doors meeting comes weeks after the shot was granted permission under emergency provisions by regulators in Britain and the United States.If EMA scientists conclude that the vaccine is safe, officials at the Amsterdam-based agency are expected to give conditional approval for it to be used across the 27-nation bloc.
The European Commission must still rubber-stamp the decision before the vaccine can be rolled out, a process German officials say could begin Dec.